The retail chemist prescription audit — what medical representatives actually collect, and why the data is so easily corrupted.
RCPA stands for Retail Chemist Prescription Audit. A medical representative visits a chemist near a doctor's clinic and records which products are moving, in what quantity, and from which competing brands. It is the field's only direct evidence of whether a doctor's stated prescribing behaviour matches what is actually being dispensed.
RCPA is the closest a pharmaceutical field force gets to ground truth. A doctor may say they are prescribing your product; the chemist's movement tells you whether that is so. The weakness is that the data is self-reported by the person whose performance it reflects, which makes capture design and validation more important than in almost any other field-sales process.
Chemists are linked to the doctors whose prescriptions they are likely to fill. Without this link the data has no interpretation.
Product, competitor brand, quantity and period, from a pick list rather than free text, so the data aggregates.
Captured during the chemist visit, with date and location, so it can be validated against the beat plan.
Outliers and implausible entries flagged for review. Unchecked self-reported data degrades quickly.
Share of movement by territory and product, compared against the doctor call plan to see where effort is converting.
A medical representative covers a doctor who claims to prescribe the company's brand regularly. Sales in the territory are flat, and the representative has no way to reconcile the two.
An RCPA at the three chemists nearest that clinic shows the molecule moving around 180 units a month, of which the company's brand accounts for 22 and a competitor for 140. The doctor is prescribing the molecule heavily and the brand rarely. That is a completely different conversation from the one the representative was preparing — it is not about convincing the doctor the molecule works, it is about why another brand is winning within it.
Used this way, RCPA converts a vague call into a specific one with evidence behind it. Used badly, it becomes a data-entry obligation where representatives record plausible numbers to close the form. The difference is whether anyone acts on the output: audits that feed into call planning and brand strategy get filled in honestly, and audits that disappear into a report nobody opens get filled in quickly.
| Term | What it means |
|---|---|
| RCPA | Retail Chemist Prescription Audit — sampling chemist sales to infer prescribing behaviour. |
| Prescriber | The doctor whose prescriptions drive demand, though they never buy the product. |
| Brand share | Your product's share of sales in a molecule category at a given outlet. |
| Competitor conversion | Shifting prescriptions from a competing brand to yours, which is what RCPA is for. |
| Chemist universe | The mapped set of outlets around a prescriber, defining where their prescriptions land. |
Makes aggregation impossible and invites inconsistency. Use a controlled product and brand list.
Self-reported data without checks drifts toward whatever reflects well on the reporter.
RCPA that is not tied to the prescribing doctors it relates to produces numbers with no action attached.
A long form during a chemist visit gets completed later from memory, which defeats the purpose.
| Metric | What it tells you | What distorts it |
|---|---|---|
| Brand share by outlet | Where you are winning and losing within the molecule, outlet by outlet. | |
| RCPA coverage | Share of key outlets audited in the period. Thin coverage makes the inference unreliable. | |
| Prescription trend after a call | Whether calls actually move behaviour, measured over the following weeks. | |
| Competitor movement | Which rival is gaining, which is the input to brand strategy rather than to call planning. |
We build and support the systems this page describes. Start with a free working proof of concept — no cost, no commitment.